Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Trial Comparing CHOP ot PMitCEBO in Good Risk Patients With Histologically Aggresive Non Hodgkin's Lymphoma

NCT00005867 is registered in ClinicalTrials.gov with Lymphoma Trials Office as lead sponsor.

NCT NCT00005867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Trial Comparing CHOP ot PMitCEBO in Good Risk Patients With Histologically Aggresive Non Hodgkin's Lymphoma
Lead sponsor
Lymphoma Trials Office
Phase
Phase 3
Overall status
Completed
Start date
January 31, 1998
Completion date
August 31, 2007
Enrollment
310 (estimated)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma